Corrigendum to “Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC [JTO Clinical and Research Reports Vol. 4 No. 1: 100431]

[This corrects the article DOI: 10.1016/j.jtocrr.2022.100431.].

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JTO clinical and research reports Jg. 6; H. 10; S. 100892
Hauptverfasser: Garassino, Marina C., Gadgeel, Shirish, Novello, Silvia, Halmos, Balazs, Felip, Enriqueta, Speranza, Giovanna, Hui, Rina, Garon, Edward B., Horinouchi, Hidehito, Sugawara, Shunichi, Rodriguez-Abreu, Delvys, Reck, Martin, Cristescu, Razvan, Aurora-Garg, Deepti, Loboda, Andrey, Lunceford, Jared, Kobie, Julie, Ayers, Mark, Piperdi, Bilal, Pietanza, M. Catherine, Paz-Ares, Luis
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States Elsevier Inc 01.10.2025
Elsevier
Schlagworte:
Hematology, Oncology, and Palliative Medicine
ISSN:2666-3643, 2666-3643
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract [This corrects the article DOI: 10.1016/j.jtocrr.2022.100431.].
AbstractList [This corrects the article DOI: 10.1016/j.jtocrr.2022.100431.].
ArticleNumber 100892
Author Garassino, Marina C.
Garon, Edward B.
Loboda, Andrey
Reck, Martin
Paz-Ares, Luis
Cristescu, Razvan
Felip, Enriqueta
Rodriguez-Abreu, Delvys
Hui, Rina
Halmos, Balazs
Pietanza, M. Catherine
Horinouchi, Hidehito
Novello, Silvia
Speranza, Giovanna
Sugawara, Shunichi
Lunceford, Jared
Aurora-Garg, Deepti
Piperdi, Bilal
Ayers, Mark
Gadgeel, Shirish
Kobie, Julie
Author_xml – sequence: 1
  givenname: Marina C.
  surname: Garassino
  fullname: Garassino, Marina C.
  email: mgarassino@medicine.bsd.uchicago.edu
  organization: Section of Hematology/Oncology, Thoracic Oncology program, University of Chicago, Chicago, Illinois, and IRCCS Istituto Nazionale dei Tumori, Milano
– sequence: 2
  givenname: Shirish
  surname: Gadgeel
  fullname: Gadgeel, Shirish
  organization: Division of Hematology/Oncology, Department of Internal Medicine, Henry Ford Cancer Institute/Henry Ford Health System, Detroit, Michigan
– sequence: 3
  givenname: Silvia
  surname: Novello
  fullname: Novello, Silvia
  organization: Department of Oncology, University of Turin, Orbassano, Italy
– sequence: 4
  givenname: Balazs
  surname: Halmos
  fullname: Halmos, Balazs
  organization: Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York
– sequence: 5
  givenname: Enriqueta
  surname: Felip
  fullname: Felip, Enriqueta
  organization: Vall d´Hebron Institute of Oncology (VHIO), Vall d´Hebron University, Barcelona, Spain
– sequence: 6
  givenname: Giovanna
  surname: Speranza
  fullname: Speranza, Giovanna
  organization: Centre integré de cancérologie de la Montérégie, Université de Sherbrooke, Greenfield Park, Quebec, Canada
– sequence: 7
  givenname: Rina
  surname: Hui
  fullname: Hui, Rina
  organization: Westmead Hospital and University of Sydney, Sydney, New South Wales, Australia
– sequence: 8
  givenname: Edward B.
  surname: Garon
  fullname: Garon, Edward B.
  organization: David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California
– sequence: 9
  givenname: Hidehito
  surname: Horinouchi
  fullname: Horinouchi, Hidehito
  organization: Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan
– sequence: 10
  givenname: Shunichi
  surname: Sugawara
  fullname: Sugawara, Shunichi
  organization: Department of Pulmonary Medicine, Sendai Kousei Hospital, Miyagi, Japan
– sequence: 11
  givenname: Delvys
  surname: Rodriguez-Abreu
  fullname: Rodriguez-Abreu, Delvys
  organization: Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
– sequence: 12
  givenname: Martin
  surname: Reck
  fullname: Reck, Martin
  organization: LungenClinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany
– sequence: 13
  givenname: Razvan
  surname: Cristescu
  fullname: Cristescu, Razvan
  organization: Merck & Co., Inc., Rahway, New Jersey
– sequence: 14
  givenname: Deepti
  surname: Aurora-Garg
  fullname: Aurora-Garg, Deepti
  organization: Merck & Co., Inc., Rahway, New Jersey
– sequence: 15
  givenname: Andrey
  surname: Loboda
  fullname: Loboda, Andrey
  organization: Merck & Co., Inc., Rahway, New Jersey
– sequence: 16
  givenname: Jared
  surname: Lunceford
  fullname: Lunceford, Jared
  organization: Merck & Co., Inc., Rahway, New Jersey
– sequence: 17
  givenname: Julie
  surname: Kobie
  fullname: Kobie, Julie
  organization: Merck & Co., Inc., Rahway, New Jersey
– sequence: 18
  givenname: Mark
  surname: Ayers
  fullname: Ayers, Mark
  organization: Merck & Co., Inc., Rahway, New Jersey
– sequence: 19
  givenname: Bilal
  surname: Piperdi
  fullname: Piperdi, Bilal
  organization: Merck & Co., Inc., Rahway, New Jersey
– sequence: 20
  givenname: M. Catherine
  surname: Pietanza
  fullname: Pietanza, M. Catherine
  organization: Merck & Co., Inc., Rahway, New Jersey
– sequence: 21
  givenname: Luis
  surname: Paz-Ares
  fullname: Paz-Ares, Luis
  organization: Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center, Universidad Complutense and Ciberonc, Madrid, Spain
BackLink https://www.ncbi.nlm.nih.gov/pubmed/41089738$$D View this record in MEDLINE/PubMed
BookMark eNqVkl1u1DAUhSNURH_oDhDyBmbwjZOMgxBSiWgpGjoVM5QHhCzHuek4JPHITpCGJxbC6lgDC8BphlIhIcSTr47P_a5_zmGw15oWg-AR0ClQSJ5U06ozytppSMPYS5Sn4b3gIEySZMKSiO3dqfeDY-cqSr0TYMbDB8F-BL5hxvhB8CMz1uprbIu-IZ0h379-O3HOKC07bVpHTElW2rkeyapvjCVv-u5mR9bkRW8LbIlsi7vq0le9I-91tyZZrVutvLjoO2Ua3MmX2OTW1PpL38icXNbenq2xMd0ardxsyRVa96d2OszGTrphkCIXy2yekQ-vV4vfQ4aDvEWH0qq1LzbGdo5cmXpKInJhpgSeEv9QEYOPD4P7pawdHu_Wo-Dd6ctV9moyX5ydZyfziWIRCydpouKIYZyCYinHMkY5A4S4UDlXkHJKc-lxSRlJFuZKMVAFyzmF2HtoWbKj4HzkFkZWYmN1I-1WGKnFjWDstZDWX6dGkRcp8LSEMJ95HC04lDEtEuBcxSyh6FmPR9amzxssbmm_vtIbotGgrHHOYnlrASqG0IhKjKERQ2jEGBrf9nxsQ_8QnzVa4ZTGVmGhLarOn1T_L0DtfuQTbtFVprc-F06AcKGgYjnkcohlGFMKQFMPePZ3wL_n_wQRyvfO
ContentType Journal Article
Copyright 2025
2025 by the International Association for the Study of Lung Cancer.
Copyright_xml – notice: 2025
– notice: 2025 by the International Association for the Study of Lung Cancer.
DBID 6I.
AAFTH
AAYXX
CITATION
NPM
DOA
DOI 10.1016/j.jtocrr.2025.100892
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
PubMed
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2666-3643
EndPage 100892
ExternalDocumentID oai_doaj_org_article_bd9189f12b7f4a0d81f50d6188c5360e
41089738
10_1016_j_jtocrr_2025_100892
S2666364325001109
1_s2_0_S2666364325001109
Genre Published Erratum
GroupedDBID .1-
.FO
0R~
1P~
53G
AAEDW
AALRI
AAXUO
AAYWO
ACVFH
ADCNI
ADVLN
AEUPX
AFJKZ
AFPUW
AFRHN
AIGII
AITUG
AJUYK
AKBMS
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
EBS
FDB
GROUPED_DOAJ
M41
M~E
OK1
ROL
RPM
Z5R
6I.
AAFTH
AAYXX
CITATION
NPM
ID FETCH-LOGICAL-c3432-96c543e591c398ef5ea71e15dcb8c19800ba4316f4a32bcc31cd3b801515d0ff3
IEDL.DBID DOA
ISSN 2666-3643
IngestDate Tue Oct 07 09:27:17 EDT 2025
Thu Oct 16 01:41:55 EDT 2025
Sat Oct 25 05:30:17 EDT 2025
Sat Nov 15 16:53:46 EST 2025
Sat Nov 22 12:30:51 EST 2025
Sat Nov 15 06:41:55 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License 2025 by the International Association for the Study of Lung Cancer.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3432-96c543e591c398ef5ea71e15dcb8c19800ba4316f4a32bcc31cd3b801515d0ff3
Notes erratum
OpenAccessLink https://doaj.org/article/bd9189f12b7f4a0d81f50d6188c5360e
PMID 41089738
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_bd9189f12b7f4a0d81f50d6188c5360e
pubmed_primary_41089738
crossref_primary_10_1016_j_jtocrr_2025_100892
elsevier_sciencedirect_doi_10_1016_j_jtocrr_2025_100892
elsevier_clinicalkeyesjournals_1_s2_0_S2666364325001109
elsevier_clinicalkey_doi_10_1016_j_jtocrr_2025_100892
PublicationCentury 2000
PublicationDate 2025-Oct
PublicationDateYYYYMMDD 2025-10-01
PublicationDate_xml – month: 10
  year: 2025
  text: 2025-Oct
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle JTO clinical and research reports
PublicationTitleAlternate JTO Clin Res Rep
PublicationYear 2025
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References 36793385 - JTO Clin Res Rep. 2022 Nov 08;4(1):100431. doi: 10.1016/j.jtocrr.2022.100431.
References_xml – reference: 36793385 - JTO Clin Res Rep. 2022 Nov 08;4(1):100431. doi: 10.1016/j.jtocrr.2022.100431.
SSID ssj0002511782
Score 2.3049886
SecondaryResourceType publication_corrigendum
Snippet [This corrects the article DOI: 10.1016/j.jtocrr.2022.100431.].
SourceID doaj
pubmed
crossref
elsevier
SourceType Open Website
Index Database
Publisher
StartPage 100892
SubjectTerms Hematology, Oncology, and Palliative Medicine
Title Corrigendum to “Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC [JTO Clinical and Research Reports Vol. 4 No. 1: 100431]
URI https://www.clinicalkey.com/#!/content/1-s2.0-S2666364325001109
https://www.clinicalkey.es/playcontent/1-s2.0-S2666364325001109
https://dx.doi.org/10.1016/j.jtocrr.2025.100892
https://www.ncbi.nlm.nih.gov/pubmed/41089738
https://doaj.org/article/bd9189f12b7f4a0d81f50d6188c5360e
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2666-3643
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002511782
  issn: 2666-3643
  databaseCode: DOA
  dateStart: 20200101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources (ISSN International Center)
  customDbUrl:
  eissn: 2666-3643
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002511782
  issn: 2666-3643
  databaseCode: M~E
  dateStart: 20200101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Li9RAEG5kEfEivh1f1MFr1nQ6j25vOuwg4swO7KgLIk13p5udZWYieQh6EH-Iv87f4A-wK481ysJ68JJDkU4lXZWqr5Oqrwl5Ypng3PI0sEpHQeyMj4PCGf-6x6kOI-W45u1mE9liwY-PxXK01RfWhHX0wN3EPdW5oH40jXTmYhXmnLokzFPKuUlYGlqMvh71jBZTGIMROPvcN_TKtQVdp3VhSqQAjRKsDeAi-iMXtZT956WkUb6ZXSfXeqAIz7sbvEEu2d1NcmXe_wq_RX5Oi7JEKs282UJdwI9v30dTXUHhYNVOKqyabVHCvKn7737QtS6A2uVjKcLOpoJ36_oEerbQDRw2tXdJ24uXdqtxl58vzVZpWG786Ug40DdxfQb8-Pa3bIa6ba2wc2ltYHE0fT2F969Wh7-V4I0MFYDQrQgqeFts9iGGRbEP9Bkg4xyjH26TN7OD1fRl0G_hEBjsWA1EapKY2URQ453CusSqjFqa5EZzQ4VHq1phM743LYu0MYyanGmfNT3MykPn2B2ytyt29h4BYXNn0pgL5TEcyyPNjIq8F9iUKuGYnZBgMKb82DF1yKGE7VR2xpdofNkZf0JeoMXPzkWe7VbgvU_23icv8r4JSQZ_kUMrqw--_kLrC5Rn542zVR9BKkllFclQHnkAlTL_wB6qIlQT45E9SOrAzz_ovNs59Nkjx9TLM8bv_4-peECuorKu0PEh2avLxj4il82nel2Vj9vX0x_nXw9-AY5PQzU
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Corrigendum+to+%E2%80%9CAssociations+of+Tissue+Tumor+Mutational+Burden+and+Mutational+Status+With+Clinical+Outcomes+With+Pembrolizumab+Plus+Chemotherapy+Versus+Chemotherapy+For+Metastatic+NSCLC+%5BJTO+Clinical+and+Research+Reports+Vol.+4+No.+1%3A+100431%5D&rft.jtitle=JTO+clinical+and+research+reports&rft.au=Garassino%2C+Marina+C.%2C+MD&rft.au=Gadgeel%2C+Shirish%2C+MD&rft.au=Novello%2C+Silvia%2C+MD%2C+PhD&rft.au=Halmos%2C+Balazs%2C+MD&rft.date=2025-10-01&rft.issn=2666-3643&rft.eissn=2666-3643&rft.volume=6&rft.issue=10&rft.spage=100892&rft.epage=100892&rft_id=info:doi/10.1016%2Fj.jtocrr.2025.100892&rft.externalDBID=ECK1-s2.0-S2666364325001109&rft.externalDocID=1_s2_0_S2666364325001109
thumbnail_m http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F26663643%2FS2666364325X00096%2Fcov150h.gif